Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lely Solari

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Revista Peruana De Medicina Experimental Y Salud Publica|February 10, 2021
Infectious agents in biological samples from patients with Guillain-Barré syndrome in Peru, 2018-2019Paul Pachas, Fernando Donaires, Ronnie G Gavilán, et al.
Vaccine|October 6, 2022
Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the Omicron wave in Peru: A nested case-control study using national population dataJavier Silva-Valencia, Percy Soto-Becerra, Stefan Escobar-Agreda, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|September 1, 2021
[First case of confirmed reinfection by SARS-CoV-2 in Peru]Luis Pampa-Espinoza, María García, Ronnie G Gavilán, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|December 9, 2020
[Reply: considerations on the evaluation under field conditions of a rapid test for detection of IgM and IgG antibodies against SARS-CoV-2]Margot Vidal-Anzardo, Gilmer Solis, Lely Solari, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|September 3, 2020
Evaluation of a rapid serological test for detection of IgM and igG antibodies against SARS-CoV-2 under field conditionsMargot Vidal-Anzardo, Gilmer Solis, Lely Solari, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|December 9, 2020
[Reply: laboratory tests for identification of SARS-CoV-2 during pandemic times in Peru: some clarification regarding «diagnostic performance»]Margot Vidal-Anzardo, Gilmer Solis, Lely Solari, et al.
Molecular Genetics & Genomic Medicine|September 12, 2021
Allelic and genotypic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patientsKelly S Levano, Luis Jaramillo-Valverde, David D Tarazona, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|December 8, 2022
IgG antibody response by ELISA using Wuhan and Lambda variant antigens in BBIBP-CORV vaccinated health care workersMaría García-Mendoza, Nancy Merino-Sarmiento, Gabriel De Lucio-Burga, et al.
Plos One|October 17, 2022
Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, PeruNatalia Vargas-Herrera, Manuel Fernández-Navarro, Nestor E Cabezudo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2010
Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected personsKrishna P Reddy, Mark F Brady, Robert H Gilman, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Revista Peruana De Medicina Experimental Y Salud Publica|February 10, 2021
Infectious agents in biological samples from patients with Guillain-Barré syndrome in Peru, 2018-2019Paul Pachas, Fernando Donaires, Ronnie G Gavilán, et al.
Vaccine|October 6, 2022
Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the Omicron wave in Peru: A nested case-control study using national population dataJavier Silva-Valencia, Percy Soto-Becerra, Stefan Escobar-Agreda, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|September 1, 2021
[First case of confirmed reinfection by SARS-CoV-2 in Peru]Luis Pampa-Espinoza, María García, Ronnie G Gavilán, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|December 9, 2020
[Reply: considerations on the evaluation under field conditions of a rapid test for detection of IgM and IgG antibodies against SARS-CoV-2]Margot Vidal-Anzardo, Gilmer Solis, Lely Solari, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|September 3, 2020
Evaluation of a rapid serological test for detection of IgM and igG antibodies against SARS-CoV-2 under field conditionsMargot Vidal-Anzardo, Gilmer Solis, Lely Solari, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|December 9, 2020
[Reply: laboratory tests for identification of SARS-CoV-2 during pandemic times in Peru: some clarification regarding «diagnostic performance»]Margot Vidal-Anzardo, Gilmer Solis, Lely Solari, et al.
Molecular Genetics & Genomic Medicine|September 12, 2021
Allelic and genotypic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patientsKelly S Levano, Luis Jaramillo-Valverde, David D Tarazona, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|December 8, 2022
IgG antibody response by ELISA using Wuhan and Lambda variant antigens in BBIBP-CORV vaccinated health care workersMaría García-Mendoza, Nancy Merino-Sarmiento, Gabriel De Lucio-Burga, et al.
Plos One|October 17, 2022
Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, PeruNatalia Vargas-Herrera, Manuel Fernández-Navarro, Nestor E Cabezudo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2010
Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected personsKrishna P Reddy, Mark F Brady, Robert H Gilman, et al.
Pageof 6